Cancer vaccines: uses of HLA transgenic mice compared to genetically modified mice

Article English OPEN
McArdle, SE;
(2008)

Many tumor antigens have been identified that can be targeted by the immune system. Animal models that have been genetically modified to express human HLA molecules instead of their own MHC antigens have shown to be valuable in the discovery of peptides derived from tum... View more
  • References (69)
    69 references, page 1 of 7

    1. van der Bruggen V, C. Traversari, P. Chomez, P. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, T. Boon. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma: Science 254, 1643-7 (1991)

    2. Palmowski M.J, U. Gileadi, M. Salio, A. Gallimore, M. Millrain, E. James, C. Addey, D. Scott, J. Dyson, E. Simpson, V. Cerundolo. Role of immunoproteasomes in cross-presentation: J Immunol 177, 983-90 (2006)

    3. Pascolo S, N. Bervas, J.M. Ure, A.G. Smith, F.A. Lemonnier, B. Perarnau. HLA-A2.1-restricted education and cytolytic activity of CD8 (+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice: J Exp Med 185 (12), 2043-51 (1997)

    4. Ramage J.M, R. Metheringham, R. Moss, I. Spendlove, R. Rees, L.D. Durrant. Comparison of the immune response to a self antigen after DNA immunisation of HLA*A201/H-2Kb and HHD transgenic mice: Vaccine 22, 1728-31 (2004)

    5. Miles A, A. Roger, R. Parkinson, R. Rees, S.E.B. McArdle: Overview of prostate biomarkers as potential targets for immunotherapy. Current Cancer Therapy Reviews. In press.

    6. Mathieu M.G, A.J Knights, G. Pawelec, C.L. Riley, D. Wernet, F.A. Lemonnier, P.T Straten, L. Mueller, R.C Rees, S.E. McArdle. HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides: Cancer Immunol Immunother 56, 1885-95 (2007)

    7. Machlenkin A, R. Azriel-Rosenfeld, I. Volovitz, E. Vadai, A. Lev, A. Paz, O. Goldberger, Y. Reiter, E. Tzehoval, I. Benhar, L. Eisenbach. Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice: Cancer Immunol Immunother 56, 217-26 (2007)

    8. Pascolo S, M. Schirle, B. Guckel, T. Dumrese, S. Stumm, S. Kayser, A. Moris, D. Wallwiener, H.G. Rammensee, S. Stevanovic: A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry. Cancer Res. 61, 4072-7 (2001)

    9. Corbet S, H.V. Nielsen, L.Vinner, S. Lauemoller, D. Therrien, S. Tang, G. Kronborg, L. Mathiesen, P. Chaplin, S. Brunak, S. Buus, A. Fomsgaard: Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes. J Gen Virol 84, 2409-21 (2003)

    10. Gritzapis A.D, N.N. Sotiriadou, M. Papamichail, C.N. Baxevanis. Generation of human tumor-specific CTLs in HLA-A2.1- transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors: Cancer Immunol Immunother 53, 1027-40 (2004)

  • Metrics
Share - Bookmark